IDEXX Laboratories, Inc. IDXX

Healthcare — Diagnostics & Research

519.26 5.87 1.14% as of 25 Sep

Market cap: $40.2B
P/E: 36.2×

Follow IDXX

S&P 500 Member Cash Flow Champion (3y)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
P/E ratio	51.33	38.39	53.85	50.00	75.34	73.40	52.65	42.96	52.60	47.42
P/S ratio	12.64	8.75	12.43	10.08	17.45	15.76	9.34	7.30	7.03	5.94
P/FCF ratio	56.88	47.28	59.64	88.38	88.83	78.94	75.78	58.79	46.70	38.49
P/Operating CF	152.94	130.12	182.09	195.77	267.19	194.85	144.69	119.12	114.35	104.73
P/B ratio	33.89	21.37	30.65	55.77	81.31	67.42	126.46	0.00	0.00	0.00
Price to Tangible BV	50.31	31.61	44.00	227.45	242.22	126.62	0.00	0.00	0.00	0.00
EV/Sales	12.71	8.83	12.49	10.28	17.67	15.95	9.72	7.52	7.10	6.06
EV/EBITDA	36.33	27.36	37.74	34.24	54.80	54.63	36.51	28.96	28.19	25.05
EV/Operating CF	46.27	37.06	50.46	63.74	75.19	66.64	50.96	41.58	37.47	31.73
EV/FCF	57.16	47.74	59.95	90.09	89.94	79.91	78.85	60.54	47.16	39.23
Quick Ratio	0.64	0.71	0.96	0.42	0.67	1.23	0.50	0.48	0.70	0.64
Current Ratio	1.23	1.31	1.57	0.89	1.25	1.82	0.94	0.85	0.97	0.90
Net Debt/EBITDA	0.18	0.26	0.20	0.65	0.68	0.66	1.42	1.53	1.59	1.89
Debt/Assets	13.42%	18.75%	21.41%	28.01%	34.88%	39.59%	54.73%	65.07%	73.60%	78.66%
Debt/Equity	0.28	0.39	0.47	1.26	1.23	1.44	5.64	(108.34)	(23.42)	(11.13)
Asset Turnover	1.30	1.19	1.22	1.30	1.36	1.31	1.43	1.36	1.21	1.18
Operating CF/Net income	1.12	1.05	1.07	0.80	1.01	1.11	1.07	1.06	1.42	1.53
Capex/Depreciation	(0.95)	(1.01)	(1.16)	(1.42)	(1.14)	(1.12)	(1.76)	(1.48)	(0.92)	(0.82)
Interest Coverage	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE	66.20%	57.66%	80.74%	104.58%	112.62%	143.54%	507.40%	(1,195.50%)	(324.76%)	(231.05%)
ROA	31.89%	27.10%	28.14%	26.20%	31.48%	28.19%	25.39%	23.20%	16.22%	14.77%
ROIC	45.33%	36.64%	39.67%	44.39%	41.74%	37.51%	31.69%	35.41%	35.11%	31.09%
Return on Tangible Assets	104.65%	84.95%	67.83%	131.82%	95.52%	56.20%	87.62%	117.46%	75.94%	82.72%
Average Days of Receivables	46.85	44.35	45.61	43.43	41.81	44.69	40.84	41.04	43.49	42.04
Research and Development Expense of Revenue	5.84%	5.64%	5.22%	7.57%	5.01%	5.22%	5.53%	5.33%	5.54%	5.70%
Selling, General and Administrative Expense of Revenue	24.36%	26.45%	24.64%	25.26%	24.77%	27.17%	28.23%	28.57%	29.21%	29.52%
Intangible Assets out of Total Assets	0.16	0.16	0.14	0.17	0.19	0.13	0.16	0.17	0.14	0.15
Share Based Compensation of Revenue	1.39%	1.55%	1.63%	1.48%	1.17%	1.14%	1.63%	1.14%	1.19%	1.12%
Graham Net Nets	(0.01)	(0.01)	(0.01)	(0.03)	(0.01)	(0.01)	(0.04)	(0.06)	(0.06)	(0.08)
Graham Number	76.94	68.47	63.95	36.47	39.91	33.71	15.18	0.00	0.00	0.00
Earnings Yield	1.95%	2.60%	1.86%	2.00%	1.33%	1.36%	1.90%	2.33%	1.90%	2.11%
Free Cash Flow Yield	1.76%	2.11%	1.68%	1.13%	1.13%	1.27%	1.32%	1.70%	2.14%	2.60%
Revenue per Share	53.51	47.26	44.07	40.27	37.74	31.72	27.95	25.48	22.43	19.79
Operating CF per Share	14.69	11.27	10.91	6.49	8.87	7.59	5.33	4.61	4.25	3.78
Capex per Share	(1.72)	(1.59)	(1.61)	(1.90)	(1.40)	(1.26)	(1.80)	(1.42)	(0.87)	(0.72)
Free Cash Flow per Share	12.98	9.68	9.30	4.59	7.46	6.33	3.53	3.19	3.38	3.06
Cash per Share	2.24	3.50	5.46	1.35	1.70	4.50	1.05	1.43	5.38	4.37
Shareholders Equity per Share	19.96	19.34	17.87	7.28	8.10	7.41	2.07	(0.11)	(0.61)	(1.21)
Interest Debt per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share	19.96	19.34	17.87	7.28	8.10	7.41	2.07	(0.11)	(0.61)	(1.21)
Free Cash Flow	1,043.58	798.08	772.88	384.15	636.00	540.44	303.93	277.15	296.57	274.16
Working Capital	265.01	331.98	543.71	(134.33)	192.08	479.98	(45.70)	(116.27)	(32.58)	(88.98)
Capital Expenditures	(138.23)	(130.92)	(133.63)	(158.84)	(119.55)	(107.63)	(155.22)	(122.94)	(76.70)	(64.79)
Net Current Asset Value	(331.55)	(298.23)	(280.14)	(1,036.55)	(791.56)	(599.03)	(975.01)	(892.41)	(795.27)	(793.33)
EV/EBIT	40.21	30.51	41.69	38.51	60.95	62.18	42.33	33.86	33.86	30.71
Capex to Sales	0.03	0.03	0.04	0.05	0.04	0.04	0.06	0.06	0.04	0.04
Net Profit Margin	24.62%	22.78%	23.08%	20.17%	23.17%	21.49%	17.77%	17.04%	13.36%	12.51%
Price to Operating Income	40.01	30.22	41.47	37.78	60.19	61.42	40.68	32.89	33.53	30.13
Other line items
Depreciation/Fixed assets	0.19	0.18	0.16	0.17	0.18	0.17	0.16	0.19	0.22	0.22
Cash ROIC	19.43%	8.63%	7.75%	(7.14%)	9.97%	4.83%	(5.88%)	(3.34%)	(0.35%)	(1.24%)
Accounts Receivable Turnover	8.39	8.37	8.53	8.76	9.19	9.01	9.29	9.16	8.97	9.04
Accounts Payable Turnover	14.64	13.51	13.32	12.04	13.91	15.48	14.70	14.24	13.72	14.20
Inventory Turnover	4.33	3.98	3.93	4.28	5.54	5.61	5.65	5.76	5.41	4.61
Average Days of Payables	24.51	27.45	27.45	29.52	31.97	23.96	25.30	26.12	28.04	27.40
Days of Inventory on Hand	83.86	91.79	94.36	98.50	74.06	67.46	68.35	65.10	68.81	72.10
Average Receivables	512.98	465.51	429.03	384.48	349.89	300.37	259.08	241.73	219.55	196.41
Average Payables	112.31	112.43	110.43	113.18	95.35	73.37	70.85	68.25	63.51	56.35
Average Inventory	379.82	381.08	374.05	318.43	239.45	202.45	184.16	168.81	161.18	173.43
Average Assets	3,322.10	3,276.68	3,003.35	2,591.98	2,365.88	2,063.52	1,684.91	1,625.38	1,622.06	1,502.85
Average Common Equity	1,600.35	1,539.92	1,046.63	649.36	661.39	405.31	84.30	(31.54)	(81.03)	(96.10)

Show all line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

IDEXX Laboratories, Inc. IDXX